Crossmark

Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: a case report

Crossref DOI link: https://doi.org/10.1186/s12885-019-5399-5

Published Online: 2019-02-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nukii, Yuki

Miyamoto, Atsushi https://orcid.org/0000-0002-3444-0536
Mochizuki, Sayaka

Moriguchi, Shuhei

Takahashi, Yui

Ogawa, Kazumasa

Murase, Kyoko

Hanada, Shigeo

Uruga, Hironori

Takaya, Hisashi

Morokawa, Nasa

Kishi, Kazuma
License Information

Text and Data Mining valid from 2019-02-28
More Information

Article History

Received: 13 December 2018

Accepted: 20 February 2019

First Online: 28 February 2019

Ethics approval and consent to participate

: This case report was approved by the local ethics committee of Toranomon Hospital (approval number #1753-B, 2018/12/11).

: Written informed consent for publication of this case report and the associated images was obtained from the patient.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below